Mosele, F., Remon, J., Mateo, J., et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol 31:11 (2020), 1491–1505.
Lamarca, A., Barriuso, J., McNamara, M.G., Valle, J.W., Molecular targeted therapies: ready for “prime time” in biliary tract cancer. J Hepatol 73:1 (2020), 170–185.
Morfouace, M., Stevovic, A., Vinches, M., et al. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN. ESMO Open, 5(6), 2020, e001075.
Blay, J.Y., Coindre, J.M., Ducimetière, F., Ray-Coquard, I., The value of research collaborations and consortia in rare cancers. Lancet Oncol 17:2 (2016), e62–e69.
Blay, J.Y., Casali, P., Bouvier, C., et al., EURACAN Network. European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN. ESMO Open, 6(4), 2021, 100174.
